Early Mobilisation in Intensive Care Unit : Interest of Cyclo-ergometry in Patients With Septic Chock (MUEVELO)

March 14, 2022 updated by: University Hospital, Rouen

Cycloergometer is a validated method for different care. This kind of device allow passive and active care for patient. The interest of cycloergometer for patient hospitalized in Intensive Care Unit for Sepsis has never been demonstrated.

The main objective of this study is to determine the impact of early mobilization by cyclo-ergometer in association with standard physiotherapy, on the ICU length in patients with septic shock

The secondary objectives of this study are to assess the impact of early mobilization by cyclo-ergometer in association with standard physiotherapy on:

  1. the duration between hemodynamic stability* and the removal of sedation
  2. the duration between the removal of sedation and ICU discharge
  3. the mechanical ventilation duration (invasive and noninvasive)

Study Overview

Study Type

Interventional

Enrollment (Actual)

122

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rouen, France
        • Rouen University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient hospitalized in ICU
  • Septic shock diagnosed more than 24 hours before inclusion
  • Patient hemodynamically stable, before the 72th hour following the diagnosis of septic shock
  • Mechanical ventilation by tracheal intubation
  • Patient sedated with a RASS score inferior or equal to -2
  • Age ≥ 18 years
  • BMI ≤ 40 kg / m²
  • Informed patient having signed the consent
  • Effective contraception in women of childbearing age (pregnancy test by B-HCG will be done; for menopausal women, a diagnosis of confirmation must be obtained).

Exclusion Criteria:

  • BMI> 40kg / m²
  • Patient reduced by one or two lower limbs
  • Rheumatological pathology, trauma or surgery of the lower limbs, pelvis or spine resulting of any limitations of the range of motions or strict immobilization
  • Brain-injured patient and / or medulla injured
  • Hemodialysis continues with a femoral catheter without possibility of changing the catheter location
  • Moribund patient, Stop or Limitation of Active Therapeutics' decision
  • Contraindications to standard physical therapy or the cyclo-ergometer
  • Untreated orthopedics: deep vein thrombosis of the member concerned
  • Dermatological: severe lesions or complex dressings in the sector concerned
  • Patient with ExtraCorporeal Membrane Oxygenation (ECMO)
  • Pregnant or breastfeeding women
  • Patient participating in another trial with the same main objective

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early mobilisation with cyclo ergometer
Early mobilisation with cyclo ergometer in addition of Standard physiotherapy during sepsis for patient with sepsis in ICU
Early mobilisation with cyclo ergometer is done daily during hospitalization for sepsis in an Intensive Care Unit
Standard physiotherapy included passive and active manual mobilization, sitting on bed, sitting in chair, walking
Active Comparator: Standard physiotherapy
Standard physiotherapy during sepsis for patient with sepsis in ICU
Standard physiotherapy included passive and active manual mobilization, sitting on bed, sitting in chair, walking

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of days between hemodynamic stability and ICU discharge
Time Frame: approximately 1 month
Number of days between hemodynamic stability (after beginning of hospitalization for sepsis) and ICU discharge
approximately 1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of days between hemodynamic stability and the removal of sedation
Time Frame: From 3 to 10 days
Number of days between hemodynamic stability (after beginning of hospitalization for sepsis) and the removal of sedation
From 3 to 10 days
Number of days under mechanical ventilation (invasive and noninvasive) during hospitalization in ICU
Time Frame: From 3 to 10 days
Number of days under mechanical ventilation (invasive and noninvasive, (after beginning of hospitalization for sepsis) ) during hospitalization in ICU
From 3 to 10 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gaétan BEDUNEAU, MD, Rouen University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 14, 2016

Primary Completion (Actual)

April 21, 2020

Study Completion (Actual)

April 21, 2020

Study Registration Dates

First Submitted

August 16, 2016

First Submitted That Met QC Criteria

August 16, 2016

First Posted (Estimate)

August 19, 2016

Study Record Updates

Last Update Posted (Actual)

March 29, 2022

Last Update Submitted That Met QC Criteria

March 14, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2014/211/HP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sepsis

Clinical Trials on Early mobilisation with cyclo ergometer

Subscribe